Active, Not Recruiting
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
NCT06271837
- Conditions
- Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer), Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Research Site Beijing, China
- Research Site Beijing, China
- Research Site Changchun, China
- Research Site Changsha, China